malondialdehyde has been researched along with fenofibrate in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 15 (57.69) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Barbanti, M; Borzatta, V; Ciriolo, MR; Cristofori, M; Mavelli, I; Rossi, L; Rotilio, G | 1 |
| Błaszczyk, J; Błaszczyk-Suszyńska, J; Gburek, J; Kedziora, J; Kowalski, J; Kowalski, M; Olejniczak, J; Petecka, E | 1 |
| Ceska, R; Hilgertová, J; Kvasnicka, J; Skrha, J; Stulc, T; Weiserová, H | 1 |
| Chen, MF; Jiang, JL; Li, YJ; Luo, BL; Yang, TL; Yu, J | 1 |
| Holubec, L; Mayer, O; Pikner, R; Simon, J; Trefil, L | 1 |
| Ahn, JY; Chung, WJ; Han, SH; Kim, JA; Koh, KK; Lee, Y; Quon, MJ; Shin, EK | 1 |
| Chen, MF; Li, YJ; Luo, BL; Xia, X; Yang, TL | 1 |
| Akin, O; Alper, M; Cindoruk, M; Erdem, O; Karakan, T; Kerem, M; Salman, B; Unal, S | 1 |
| Meng, Q; Ruan, X; Shen, C | 1 |
| Zhou, JY; Zhou, SW | 1 |
| Boshra, V; Moustafa, AM | 1 |
| Chen, ZY; Lei, L; Li, LY; Liu, Q; Liu, SN; Shen, ZF; Zhang, N | 1 |
| Huan, Y; Li, LY; Liu, Q; Liu, SN; Shen, ZF; Sun, SJ | 1 |
| Akın, O; Alper, M; Cindoruk, M; Engin, D; Karakan, T; Kerem, M | 1 |
| Abdel Kawy, HS; El-Aziz, LF; El-Kharashi, OA; El-Samad, AA; Elmelegy, AA; Mohamed, DI | 1 |
| Elshazly, SM; Mahmoud, AA | 1 |
| Huang, F; Jiang, J; Sun, B; Wang, Y; Xie, Y; Xu, X; Zhao, C | 1 |
| Cui, Y; Deng, M; Qi, ZG; Shang, X; Wang, XL; Xie, ML; Xue, J; Zhang, Y; Zhao, X | 1 |
| Liu, H; Ma, X; Zheng, X; Zuo, N | 1 |
| Abd El-Haleim, EA; Bahgat, AK; Saleh, S | 1 |
| Refaie, MMM | 1 |
| Mohammadi, MT; Sahebkar, A; Yaribeygi, H | 1 |
| Refaie, MMM; Rifaai, RA; Zenhom, NM | 1 |
| Abdel-Hafez, SMN; Abdelzaher, WY; Ali, AHSA; Bahaa, HA; Hegazy, A; Rofaeil, RR | 1 |
| Abdelzaher, WY; Bayoumi, AMA; El-Tahawy, NFG; Refaie, MMM; Shehata, S | 1 |
| Bilušić, M; Božina, T; Bradamante, V; Konjevoda, P; Lovrić, J; Rašić, D; Vukšić, A; Žunec, S | 1 |
5 trial(s) available for malondialdehyde and fenofibrate
| Article | Year |
|---|---|
[Effect of fluvastatin and fenofibrate on reactive oxygen species generation and lipid peroxidation in patients with dyslipidemia].
Topics: Adult; Aged; Anticholesteremic Agents; Fatty Acids, Monounsaturated; Female; Fenofibrate; Fluvastatin; Humans; Hyperlipidemias; Hypolipidemic Agents; Indoles; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Reactive Oxygen Species | 2003 |
Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes.
Topics: Acetylglucosaminidase; Adult; Aged; alpha-Tocopherol; Ascorbic Acid; Cholesterol; Czech Republic; Diabetes Mellitus, Type 2; Drug Administration Schedule; E-Selectin; Endothelium; Female; Fenofibrate; Fibrinolysis; Glutathione; Humans; Hyperlipidemias; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Plasminogen Activator Inhibitor 1; Simvastatin; Superoxide Dismutase; Time Factors; Triglycerides; Vascular Endothelial Growth Factor A; von Willebrand Factor | 2004 |
Folate co-administration improves the effectiveness of fenofibrate to decrease the lipoprotein oxidation and endothelial dysfunction surrogates.
Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Drug Therapy, Combination; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Fenofibrate; Fluvastatin; Folic Acid; Homocysteine; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Prospective Studies; Thrombomodulin; Treatment Outcome; Triglycerides; Vitamin B Complex; von Willebrand Factor | 2006 |
Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Lipoproteins; Male; Malondialdehyde; Middle Aged; Multivariate Analysis; Regression Analysis; Tetrazoles; Vasomotor System | 2006 |
Effect of fenofibrate on the level of asymmetric dimethylarginine in individuals with hypertriglyceridemia.
Topics: Adult; Anticholesteremic Agents; Arginine; Blood Flow Velocity; Brachial Artery; Cholesterol; Cholesterol, HDL; Diet; Endothelium, Vascular; Female; Fenofibrate; Humans; Hypertriglyceridemia; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha; Vasodilation | 2006 |
21 other study(ies) available for malondialdehyde and fenofibrate
| Article | Year |
|---|---|
The effects of hypolipidemic agents derived from procetofenic acid on the activity of superoxide dismutase and glutathione peroxidase and on malonyl dialdehyde production of rat liver.
Topics: Animals; Catalase; Cholesterol; Female; Fenofibrate; Glutathione Peroxidase; Hypolipidemic Agents; In Vitro Techniques; Lipid Peroxides; Liver; Male; Malonates; Malondialdehyde; Propionates; Rats; Rats, Inbred Strains; Sex Factors; Superoxide Dismutase; Triglycerides | 1984 |
Effect of fenofibrate on LDL-induced endothelial dysfunction in rats.
Topics: Acetylcholine; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Arginine; Creatinine; Endothelium, Vascular; Fenofibrate; Hypolipidemic Agents; In Vitro Techniques; Male; Malondialdehyde; Muscle, Smooth, Vascular; Nitrates; Nitrites; Phenylephrine; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Vasodilation | 2004 |
Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study.
Topics: Animals; Apoptosis; Bile Ducts; Bilirubin; Cholestasis; Cytokines; Fenofibrate; Hepatocytes; Inflammation Mediators; Jaundice, Obstructive; Ligation; Liver; Male; Malondialdehyde; PPAR alpha; Rats; Rats, Wistar | 2007 |
Establishment of a methodology for investigating protectants against ethanol-induced hepatotoxicity.
Topics: Animals; Antioxidants; Cell Culture Techniques; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chemoprevention; Ethanol; Fenofibrate; Hepatocytes; Hypolipidemic Agents; Male; Malondialdehyde; Nanoparticles; Nanotechnology; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Silybin; Silybum marianum; Silymarin | 2010 |
Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver.
Topics: Animals; Antioxidants; Berberine; Coptis; Cyclin T; Cyclin-Dependent Kinase 9; Diabetes Mellitus, Experimental; Diet; Drugs, Chinese Herbal; Enzymes; Fenofibrate; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Peroxidation; Liver; Male; Malondialdehyde; Phytotherapy; Positive Transcriptional Elongation Factor B; Rats; Rats, Wistar; Rhizome; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2011 |
Effect of preischemic treatment with fenofibrate, a peroxisome proliferator-activated receptor-α ligand, on hepatic ischemia-reperfusion injury in rats.
Topics: Alanine Transaminase; Animals; Endothelium; Fenofibrate; Hepatic Stellate Cells; Hepatocytes; Ischemia; Kupffer Cells; Liver; Male; Malondialdehyde; PPAR alpha; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2011 |
[A dyslipidemia animal model induced by poloxamer 407 in golden hamsters and pilot study on the mechanism].
Topics: Animals; Anticholesteremic Agents; Atorvastatin; CD36 Antigens; Cricetinae; Disease Models, Animal; Dyslipidemias; Fenofibrate; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Malondialdehyde; Mesocricetus; Nitric Oxide; Phosphatidylcholine-Sterol O-Acyltransferase; Poloxamer; PPAR alpha; Pyrroles; RNA, Messenger; Superoxide Dismutase | 2011 |
Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: is that a latent disadvantage?
Topics: Adenosine Triphosphatases; Animals; Blood Glucose; Dyslipidemias; Fenofibrate; Glucose; Homeostasis; Insulin; Insulin Secretion; Malondialdehyde; Mitochondria; NF-kappa B; Nitric Oxide Synthase Type II; Obesity; Pancreas; Protein Transport; Rats; Rats, Wistar; Sodium Glutamate; Time Factors; Up-Regulation | 2011 |
PPAR-alpha agonist treatment increases trefoil factor family-3 expression and attenuates apoptosis in the liver tissue of bile duct-ligated rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Apoptosis; Aspartate Aminotransferases; Bile Ducts; Bilirubin; Fenofibrate; gamma-Glutamyltransferase; Hypolipidemic Agents; Interleukin-1beta; Ligation; Lipid Peroxidation; Liver; Male; Malondialdehyde; Neuropeptides; PPAR alpha; Rats; Rats, Wistar; RNA, Messenger; Trefoil Factor-3; Tumor Necrosis Factor-alpha | 2013 |
Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Concanavalin A; Fenofibrate; Hepatitis; Liver; Male; Malondialdehyde; Oxidative Stress; Portal Pressure; PPAR alpha; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2013 |
Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Fenofibrate; Fructose; Glutathione; Glycation End Products, Advanced; Insulin; Insulin Resistance; Male; Malondialdehyde; Metabolic Syndrome; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Wistar; Triglycerides; Uric Acid; Ursodeoxycholic Acid | 2014 |
Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.
Topics: Animals; Apolipoprotein A-I; Arginine; C-Reactive Protein; Cardiotonic Agents; Cholesterol, HDL; Dose-Response Relationship, Drug; Fenofibrate; Hypertriglyceridemia; Hypolipidemic Agents; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Sprague-Dawley; Triglycerides | 2015 |
PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
Topics: Anilides; Animals; Chemokine CCL2; Cytokines; Disease Models, Animal; Fatty Acids, Nonesterified; Fenofibrate; Gene Expression Regulation; Glutathione; Indoles; Inflammation; Interleukin-6; Interleukin-8; Lipid Metabolism; Liver; Male; Malondialdehyde; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
Topics: Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Chemokine CCL2; Cytoprotection; Dose-Response Relationship, Drug; Fatty Acids; Fenofibrate; Humans; Interleukin-8; Kidney Tubules, Proximal; Malondialdehyde; NF-kappa B; Oxidative Stress; PPAR alpha; Protein Binding; Serum Albumin, Bovine; Signal Transduction; Superoxide Dismutase; Transcription, Genetic; Transcriptional Activation; Up-Regulation | 2015 |
Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Topics: Adiponectin; Adipose Tissue; Animals; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Fenofibrate; Fructose; Gene Expression Regulation; Glutathione; Homeostasis; Insulin; Leptin; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Pioglitazone; PPAR alpha; PPAR gamma; Rats; Rats, Wistar; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
Upregulation of peroxisome proliferator activated receptor alpha by fenofibrate in induced testicular ischemia reperfusion.
Topics: Animals; Apoptosis; Fenofibrate; Glutathione; Ischemia; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; PPAR alpha; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase; Testis; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation | 2018 |
PPAR-α Agonist Improves Hyperglycemia-Induced Oxidative Stress in Pancreatic Cells by Potentiating Antioxidant Defense System.
Topics: Animals; Antioxidants; Catalase; Diabetes Mellitus, Experimental; Fenofibrate; Glutathione; Hyperglycemia; Male; Malondialdehyde; Nitrates; Oxidative Stress; Pancreas; PPAR alpha; Rats; Superoxide Dismutase | 2018 |
Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Topics: Animals; Antioxidants; Dihydrotestosterone; Fenofibrate; Glutathione Peroxidase; Male; Malondialdehyde; PPAR alpha; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats; Rats, Wistar; Superoxide Dismutase; Testosterone | 2018 |
The protective effect of fenofibrate, triptorelin, and their combination against premature ovarian failure in rats.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Combinations; Drug Therapy, Combination; Female; Fenofibrate; Glutathione; Hormones; Interleukin-10; Malondialdehyde; Nitrites; Ovary; Oxidative Stress; Primary Ovarian Insufficiency; Protective Agents; Rats, Wistar; Superoxide Dismutase; Triptorelin Pamoate; Tumor Necrosis Factor-alpha | 2021 |
The IL-6/STAT Signaling Pathway and PPARα Are Involved in Mediating the Dose-Dependent Cardioprotective Effects of Fenofibrate in 5-Fluorouracil-Induced Cardiotoxicity.
Topics: Antioxidants; Cardiotoxicity; Caspase 3; Fenofibrate; Fluorouracil; Glutathione; Humans; Interleukin-6; Malondialdehyde; Oxidative Stress; PPAR alpha; Signal Transduction; STAT4 Transcription Factor | 2022 |
The effects of simvastatin and fenofibrate on malondialdehyde and reduced glutathione concentrations in the plasma, liver, and brain of normolipidaemic and hyperlipidaemic rats.
Topics: Animals; Antioxidants; Brain; Fenofibrate; Glutathione; Liver; Male; Malondialdehyde; Rats; Rats, Wistar; Rats, Zucker; Simvastatin | 2023 |